Led · Seed · Jul 2026

DITTO Daily develops a flagship Cycle Supplement that uses beadlet-in-oil time-release technology to deliver 10 clinically supported ingredients aimed at reducing PMS and PMDD symptoms. In a clinical trial cited by the company, 88% of participants reported reduced symptom severity. The company emphasizes translating academic research into accessible guidance and has grown a community to 300,000 members in 18 months. Founded in 2024, DITTO’s team has expanded to 15 employees and includes medical advisors such as a gynaecologist and a women’s health GP. The funding will support expansion of the supplement and further clinical research, including trials investigating a potential overlap between PMDD and ADHD and plans to conduct three additional trials and publish five papers over the next year.

Participated · Series A · Jul 2026

Founded in 2024 and based in Berlin, dsb offers certified energy consulting where consultants collect building data to create a digital twin and an individual renovation roadmap (iSFP). The company reviews and handles subsidy applications through KfW and BAFA and coordinates implementation of measures such as solar panels, heat pumps, window replacement, and insulation via a network of vetted trades businesses. dsb says its process reduces the homeowner's time requirement by approximately 80%. Since founding it has tripled in size and now serves over 10,000 private customers and works with around 300 local skilled trades businesses. The company forecasts revenue exceeding €15 million for 2026. Planned product and go-to-market moves include launching a proprietary electricity tariff and expanding into the B2B market.

Participated · Series A · Jul 2026

Founded in 2024 by Neil Saada and Neil Marrakchi, Reformed sells pouches of instant specialty-grade arabica coffee and ceremonial matcha that include 21 vitamins and minerals, functional mushrooms (lion’s mane and chaga) and either 15g collagen or 5g creatine. The products are offered caffeinated or decaf (coffee) and come in multiple flavors; they can be prepared hot or cold and mixed with milk or water. Reformed operates primarily on a direct-to-consumer subscription model with pricing starting at £39.99 per month, and it also sells branded accessories and has selective retail presence (including Selfridges). The company has scaled profitably to $70 million in annual revenue within two years and reports particularly strong growth among health-focused consumers in central London. Reformed plans to expand into the U.S. in the third quarter and intends to prioritize controlled, quality-focused growth rather than mass retail distribution.

Participated · Seed · Jul 2026

Founded in 2025 and based in Wageningen, Aardaia builds a breeding platform that combines whole-genome sequencing, computational biology and phenotyping to identify and domesticate wild plant species. The company explicitly avoids genetic modification and gene editing, instead accelerating conventional breeding through predictive genomics and high-throughput evaluation. Its first product, the aardaker, is a protein-rich tuber intended to combine root-crop productivity with legume-like nitrogen-fixing properties and to reduce reliance on imported protein crops while requiring no synthetic nitrogen fertilizer. Aardaia expects to screen about 750,000 unique aardaker genotypes this year and plans to scale that to roughly two million with the new funding. The €5 million seed raise will be used to expand the breeding platform and speed development of the aardaker as it continues to create new crop varieties from wild species.

Participated · Series A · May 2026

Pacifico Biolabs develops protein ingredients using mycelium fermentation technology and produces them in standard beer brewery fermentation tanks rather than purpose-built bioreactors. By repurposing existing brewery infrastructure the company seeks to lower production costs and scale more quickly using underutilised fermentation capacity. Pacifico positions its product as a domestically produced protein alternative to imported feed protein, aiming to shorten supply chains and reduce environmental and geopolitical exposure. The company plans to scale production in Saxony, Germany, expand its team, and roll out commercial launches across the DACH region and Nordic Europe, targeting retail launches by late 2026. The recent €7 million Series A will fund those near-term expansion and commercialization efforts.